Norris Medicines Ltd.
| BSE: 524414 | Sector: Others |
| NSE: N.A. | ISIN Code: INE744C01029 |
| BSE 00:00 | 17 May | 24.55 |
0 (0.00%) |
OPEN
24.55 |
HIGH
24.55 |
LOW
24.55 |
| NSE 05:30 | 01 Jan | Norris Medicines Ltd |
| OPEN | 24.55 |
| PREVIOUS CLOSE | 24.55 |
| VOLUME | 14 |
| 52-Week high | 36.75 |
| 52-Week low | 5.75 |
| P/E | |
| Mkt Cap.(Rs cr) | 25 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Norris Medicines Ltd. (NORRISMEDICINES) - Announcements
-
Norris Medicines Ltd Board Meeting Intimation for To Consider Audited Financial Results For The Quarter And Year Ended O
16/05/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
20/04/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Submission Of Certificate Under Reg. 40(9) For The Period Ended March 31 2021
20/04/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Submission Of Certificate Under Regulation 7(3) For The Period Ended 31St March 2022
11/04/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
05/04/2022 | bse
-
Norris Medicines Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05/04/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Revision In Policy On Materiality Of Events & Its Disclosures
13/02/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Standalone Unaudited Financial Results In Compliance<BR> With Regulation 33 Of SEBI (LODR) RegUlatio
12/02/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Board Meeting Outcome for Outcome Of Board Meeting
12/02/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Board Meeting Intimation for Consider And Approval Of Unaudited Standalone Financial Results Of The
02/02/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Shareholding for the Period Ended December 31 2021
13/01/2022 | bse
-
Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended December 2021
06/01/2022 | bse
-
Norris Medicines Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06/01/2022 | bse |
Downlaod PDF -
Norris Medicines Ltd Closure of Trading Window
31/12/2021 | bse |
Downlaod PDF -
Norris Medicines Ltd Submission Of Standalone Unaudited Financial Results In Compliance With Regulation 33 Of SEBI (LODR)
12/11/2021 | bse |
Downlaod PDF -
Norris Medicines Ltd Board Meeting Outcome for Outcome Of Board Meeting <BR>
12/11/2021 | bse |
Downlaod PDF -
Norris Medicines Ltd Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results Of The Company For T
30/10/2021 | bse |
Downlaod PDF -
Norris Medicines Ltd Shareholding for the Period Ended September 30 2021
20/10/2021 | bse
-
Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended September 2021
04/10/2021 | bse
Quick Links for Norris Medicines:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
